[HTML] from ascopubs.orgR Beverly Raney, DO Walterhouse… - Journal of Clinical …, 2011 - jco.ascopubs.org Purpose Patients with localized, grossly resected, or gross residual (orbital only) embryonal rhabdomyosarcoma (ERMS) had 5-year failure-free survival (FFS) rates of 83% and overall survival rates of 95% on Intergroup Rhabdomyosarcoma Study Group (IRSG) protocols III/IV. IRSG D9602 ... Cited by 1 - Related articles - All 7 versions
[HTML] from 171.66.121.246RJ Osborne, V Filiaci, JC Schink… - Journal of Clinical …, 2011 - 171.66.121.246 From the Odette Cancer Centre, Toronto, Ontario; University of Montreal, Montreal, Quebec, Canada; Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, NY; Northwestern University Feinberg School of Medicine, Chicago, IL; ... Cited by 3 - Related articles - All 6 versions
F Feng, Y Xiang, X Wan, S Geng… - Annals of …, 2011 - Eur Soc Med Oncology Background: Although most patients with gestational trophoblastic neoplasia (GTN) are cured by conventional chemotherapy, some develop drug resistance or relapse. The use of new combination drugs has been studied to treat those with resistant or relapsed disease. We evaluated ... Related articles - All 4 versions
[HTML] from jcojournal.orgC Aghajanian - Journal of Clinical Oncology, 2011 - jcojournal.org ... In this issue of Journal of Clinical Oncology, Osborne et al 4 report the results of a randomized phase III trial performed by the Gynecologic Oncology Group of weekly methotrexate versus pulsed dactinomycin for low-risk GTN. ... Related articles - All 5 versions
[PDF] from hindawi.comJ Wang… - 2011 - downloads.hindawi.com ... The patient developed liver metastasis three months after initial diagnosis. He was treated with a chemotherapy regimen with vincristine, dactinomycin, and cyclophosphamide (VAC) alternating with vincristine and irinotecan (VI) with complete resolution of his liver lesion. ... Related articles - View as HTML - All 2 versions